ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: PP12

We Became Advocates, Educators, and a Support System for Hispanic/Latino Patients with Rheumatoid Arthritis and Their Caregivers Through Involvement in a Virtual Patient Advisory Board

Zucy Almonacid1, Wigna Cruz2, Francisca Garcia3, Teresa Hernandez4, Velia Martinez5, Patricia Mattos3, Mario Mutis6 and Denise Serrano7, 1Hicsville, NY, 2Juan Diaz, PR, 3Lake Worth, FL, 4Greenacres, FL, 5Guaynabo, PR, 6Fort Pierce, FL, 7Toa Alto, PR

Meeting: ACR Convergence 2022

Keywords: Access to care, education, patient, Patient reported outcomes, population studies, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Patient Perspectives Poster

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: Each of us has been diagnosed with rheumatoid arthritis (RA), from as recently as one year ago to as long as 20 years ago. All of us receive RA treatment from a rheumatologist in the US or Puerto Rico. We were each invited to participate on a patient advisory board convened by The Global Healthy Living Foundation (GHLF). Invitations were made by our rheumatologists, who are participating in research in collaboration with GHLF, or via GHLF’s Spanish-language website, CreakyJointsEspañol on the website landing page or with an associated WhatsApp tool. We all completed an informed consent (Pro00050365) process before participating.

Intervention: The objective of the advisory board was to provide guidance and support for research among Spanish-speaking RA patients in the US and Puerto Rico. Weekly advisory board meetings were facilitated by a Spanish-speaking staff member of GHLF. Initially, we met using the What’s App chat feature. As our relationships grew and trust was built, we transitioned to using Zoom online audiovisual conferencing for our meetings. We were presented with Spanish-language educational information on five topics related to RA (Table 1) and asked to share our experiences related to these educational topics. We discussed how the materials could be made more accessible or “patient-friendly” to Spanish-speaking RA patients.

We provided feedback on Spanish-language pre- and post-tests that were being developed as part of an online educational guide to RA for patients, which is hosted on CreakyJointsEspañol (www.cjes.org). This educational material is also being used in GHLF’s research on the impacts of Spanish language-first patient education for Hispanic/Latino patients with RA. We also reviewed and gave feedback on an in-office assessment tool for this research: the patient-provider questionnaire (PPQ)
Throughout the intervention, we were asked to think about our own experiences with RA and what would have made us feel more equipped to manage our RA.

Maintenance: We have learned about our RA through this intervention and continue meeting as a group with GHLF. Together we are researching “the Spanish-speaking RA patient journey,” and creating educational videos to be shared on the CreakyJointsEspañol website. We have developed innovative ways and new skills to reach our community, such as a musical RA awareness campaign and participating in local news interviews. We are in frequent contact with one another through a WhatsApp chat group.

Quality of Life: We have formed a strong bond and consider each other friends who make up a strong support system. Some of us have experienced flares, COVID-19, and other challenges during our participation, and we have felt supported and heard by this community. We also believe that being a part of this advisory board has given us the confidence and tools to improve our communication about RA with our healthcare teams and our communities.

Supporting image 1

Supporting image 2

Image 1. Patient Advisory Board Zoom Call

Supporting image 3

Image 2. Television interview with Patient Advisory Board Member, Wigna Cruz, for Arthitis Awareness Month (Mes de la Concientización de la artritis), May 2022


Disclosures: Z. Almonacid, Bristol-Myers Squibb(BMS) Foundation; W. Cruz, Bristol-Myers Squibb(BMS) Foundation; F. Garcia, Bristol-Myers Squibb(BMS) Foundation; T. Hernandez, Bristol-Myers Squibb(BMS) Foundation; V. Martinez, Bristol-Myers Squibb(BMS) Foundation; P. Mattos, Bristol-Myers Squibb(BMS) Foundation; M. Mutis, Bristol-Myers Squibb(BMS) Foundation; D. Serrano, BMS Foundation.

To cite this abstract in AMA style:

Almonacid Z, Cruz W, Garcia F, Hernandez T, Martinez V, Mattos P, Mutis M, Serrano D. We Became Advocates, Educators, and a Support System for Hispanic/Latino Patients with Rheumatoid Arthritis and Their Caregivers Through Involvement in a Virtual Patient Advisory Board [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/we-became-advocates-educators-and-a-support-system-for-hispanic-latino-patients-with-rheumatoid-arthritis-and-their-caregivers-through-involvement-in-a-virtual-patient-advisory-board/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/we-became-advocates-educators-and-a-support-system-for-hispanic-latino-patients-with-rheumatoid-arthritis-and-their-caregivers-through-involvement-in-a-virtual-patient-advisory-board/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology